Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

NCT05655546 is registered in ClinicalTrials.gov with Scripps Translational Science Institute as lead sponsor.

NCT NCT05655546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05655546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Lead sponsor
Scripps Translational Science Institute
Phase
Not applicable
Overall status
Terminated
Start date
December 22, 2022
Completion date
June 20, 2024
Enrollment
2,117 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related immunodeficiency, cancer, graft versus host disease, hiv infections, immunodeficiency, immunosuppression, leukemia, lymphoma, multiple myeloma, transplant